Dx dialogues: blood-based biomarkers and other diagnostic tools for Alzheimer's and related dementias
Dx dialogues: overlapping symptomatology of Alzheimer's and other neurodegenerative disorders
Dx dialogues: novel approaches in development for the treatment of AD
Dx dialogues: considerations when deciding whether to initiate pharmacologic interventions for patients with AD
Should our goal be to prevent Alzheimer's disease or to treat it?
Are we spending enough on Alzheimer's research?
If Alzheimer's disease is incurable, can we delay its onset?
Dx dialogues: how AI can be integrated in the management of AD
Why I care: why Dr. Heather Snyder is driven to educate others
How can I reduce my risk of Alzheimer's disease?
The FDA approved the drug lecanemab in 2023. Learn where treatment stands for this progressive disease.
Sticking with your medication plan can be tough, but tools in the Sharecare app can help you stay the course.
Try these tips to reduce your chances of a potentially harmful mistake.
Learn why hypertension in older adults is linked with stroke and dementia.
What is "frozen shoulder" exactly and why are some people more at risk than others?